Morgan Stanley Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight
Tweet
Share
E-mailGet Alerts ENDP Hot Sheet
Price: $0.29 --0%
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Morgan Stanley upgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $66.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Nomura/Instinet Upgrades Sunway Healthcare Holdings (SUNMED:MK) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
